Here are four things to know:
1. The regenerative medicine company resumed global distribution of Hyalofast, Hyalograft-C and Hyalomatrix.
2. Hyalofast is a biodegradable HA-based scaffold for hyaline-like cartilage regeneration to treat cartilage defects and injuries.
3. Following recent regulatory approvals in Thailand, the United Arab Emirates and Colombia, Hyalofast is now used in 15 countries.
4. Anika Therapeutics develops, manufactures and commercializes more than 20 products based on its proprietary HA technology.
More articles on biologics:
AlloSource earns laser etching patent: 3 notes
4 things to know about Bio2 Technologies
Spine biologics market to reach $2.72B by 2025 — 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
